U.S. markets close in 2 hours 10 minutes
  • S&P 500

    3,627.94
    -27.10 (-0.74%)
     
  • Dow 30

    28,994.25
    -266.56 (-0.91%)
     
  • Nasdaq

    10,763.37
    -39.55 (-0.37%)
     
  • Russell 2000

    1,654.43
    -1.45 (-0.09%)
     
  • Crude Oil

    78.50
    +1.79 (+2.33%)
     
  • Gold

    1,635.20
    +1.80 (+0.11%)
     
  • Silver

    18.34
    -0.14 (-0.73%)
     
  • EUR/USD

    0.9586
    -0.0026 (-0.27%)
     
  • 10-Yr Bond

    3.9760
    +0.0980 (+2.53%)
     
  • GBP/USD

    1.0685
    +0.0002 (+0.02%)
     
  • USD/JPY

    144.8520
    +0.1720 (+0.12%)
     
  • BTC-USD

    18,972.46
    -114.17 (-0.60%)
     
  • CMC Crypto 200

    436.18
    -22.96 (-5.00%)
     
  • FTSE 100

    6,984.59
    -36.36 (-0.52%)
     
  • Nikkei 225

    26,571.87
    +140.32 (+0.53%)
     

Dow Futures Extend Declines After Powell Reiterates Hawkish Stance

·1 min read

By Oliver Gray

Investing.com - U.S. stock futures were trading lower during Sunday’s evening deals, after major benchmark indices retreated on Friday following Fed Chair Powell’s comments at the Jackson Hole Symposium, signaling a willingness to hike interest rates even if it causes economic pain.

By 7:00pm ET (11:00pm GMT) Dow Jones Futures were down 0.6%, S&P 500 Futures fell 0.8% and Nasdaq 100 Futures fell 1%.

Ahead in the week, market participants will be monitoring more speeches from Federal Reserve officials, as well as ADP Employment Change, JOLTs Job Openings and ISM manufacturing PMI data. Key Nonfarm Payrolls data will also be closely watched, with the economy expected to add 285k positions and unemployment to hold at 5%.

During Friday’s regular trade, the Dow Jones Industrial Average fell 1,008 points or 3% to 32,283.4, the S&P 500 shed 141.5 points or 3.4% to 4,057.7 and the NASDAQ Composite fell 3.9% to 12,141.7.

On the bond markets, United States 10-Year rates were at 3.043%.

Related Articles

Dow Futures Extend Declines After Powell Reiterates Hawkish Stance

NASA's mega-moon rocket ready for liftoff on eve of debut Artemis mission

China's CanSinoBIO H1 revenue drops on weaker COVID shot demand